NEW YORK ( TheStreet) -- Shares of Array BioPharma (Nasdaq: ARRY) were gapping down Wednesday morning with an open price 10% lower than Tuesday's closing price. The stock closed at $2.39 Tuesday and opened today's trading at $2.15.

The average volume for Array BioPharma has been 417,700 shares per day over the past 30 days. Array BioPharma has a market cap of $116.9 million and is part of the health care sector and drugs industry. Shares are down 20.1% year to date as of the close of trading on Tuesday.

Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients with cancer, inflammatory, and metabolic diseases in North America, Europe, and Asia Pacific.

TheStreet Ratings rates Array BioPharma as a sell. The company's weaknesses can be seen in multiple areas, such as its generally disappointing historical performance in the stock itself and weak operating cash flow. You can view the full Array BioPharma Ratings Report.

Get more investment ideas from our investment research center.

Interested in other stocks that are gapping down? Get free SMS text alerts sent to you when the action happens by texting DOWN to 95370 or select from multiple alert options.
null

If you liked this article you might like

STMicroelectronics, Intercept Pharmaceuticals: 'Mad Money' Lightning Round

Watch Out For the Dominoes That Fall: Cramer's 'Mad Money' Recap (Wed 9/20/17)

Mirati Skyrockets On Positive Data - Biotech Movers

Array BioPharma Seems to Be in a New Uptrend